(Q43276366)
Statements
Preclinical biomarkers for a cyclin-dependent kinase inhibitor translate to candidate pharmacodynamic biomarkers in phase I patients (English)
Windy Berkofsky-Fessler
Tri Q Nguyen
Juliette Molnos
Charu Kanwal
Wanda DePinto
James Rosinski
Patricia McLoughlin
Steve Ritland
Mark DeMario
Krishna Tobon
John F Reidhaar-Olson
Ruediger Rueger
15 September 2009